NCT02708771

Effect of W-3 Polyunsaturated Fatty Acids on Serum Albumin Concentration in Patients With Acute Heart Failure, Hypoalbuminemia, and High Inflammatory Activity

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 42 (actual)
• Sponsor: Hospital San Juan de la Cruz · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Assess whether high doses of ?-3 fatty acids added to standard treatment of patients with acute hearta failure, hypoalbuminemia and high inflammatory activity, promotes an increase in serum albumin

Detailed description

Assess whether high doses of ?-3 fatty acids added to standard treatment of patients with acute hearta failure, hypoalbuminemia and high inflammatory activity, promotes an increase in serum albumin Assess the effect of high doses of ?-3 fatty acids added to standard treatment of patients with acute hearta failure, hypoalbuminemia and high inflammatory activity on: * Inflammatory activity (C-reactive protein) * The development of biomarkers (NTproBNP). * The prognosis of patients evaluated by the combined event of death from any cause or readmission for heart failure within three months after randomization.

Conditions

• Heart Failure

Interventions

Type	Name	Description
DRUG	Polyunsaturated fatty acids omega-3	4 daily capsules of polyunsaturated fatty acids omega-3, during 4 weeks. Each capsule contains: 460 mg eicosapentaenoic acid ethyl ester and 380 mg docosahexaenoic acid ethyl ester.
DRUG	Placebo	4 daily capsules of similar appearance and flavor without active ingredient

Timeline

• Start date: 2016-03-01
• Primary completion: 2018-06-01
• Completion: 2018-06-01
• First posted: 2016-03-15
• Last updated: 2021-02-10

Locations

1 site across 1 country: Spain